Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 23, 2017 ) According to Publisher, the Global Bioabsorbable Stents Market is accounted for $0.35 billion in 2015 and is expected to reach $3.56 billion by 2022 growing at a CAGR of 39.2% during the forecast period. Factors such as expanding geriatric population, increased usage rate of these stents and rise in cardiovascular surgeries are boosting the market growth. However, strict regulations and huge cost of these stents are hampering the market. For more information http://www.reportsweb.com/bioabsorbable-stents-global-market-outlook-2016-2022
By absorption rate, slow absorbable stents segment dominated the global market with largest share owing to the longer duration of drug discharge within the arteries. By region, North America accounted for largest market share. However, Asia Pacific is anticipated to witness highest CAGR, due to rising awareness in the region.
Some of the key players in Bioabsorbable Stents market include Arterial Remodeling Technology SA, Boston Scientific Corporation, Medtronic, Abbott Laboratories, B. Braun Melsungen AG, Kyoto Medical Planning Co., Ltd., Amaranth Medical, Inc., Stentys SA, Elixir Medical Corporation, Arterius Limited, REVA Medical, Inc., Xenogenics Corporation, Microport Scientific Corporation, Tepha, Inc., C. R. Bard, Inc., Terumo Corporation, Meril Life Sciences and Biotronik.
Drugs Covered: - Limus-Based Drugs - Paclitaxel
Product Types Covered: - Metallic Stents - Natural - Polymeric Stents
Applications Covered: - Peripheral Artery Disease - Coronary Artery Disease
End Users Covered: - Cardiac Centers - Hospitals
Absorption Rates Covered: - Fast-Absorption Stents - Slow-Absorption Stents
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001564982/sample
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
12 Company Profiling 12.1 Arterial Remodeling Technology SA 12.2 Boston Scientific Corporation 12.3 Medtronic 12.4 Abbott Laboratories 12.5 B. Braun Melsungen AG 12.6 Kyoto Medical Planning Co., Ltd. 12.7 Amaranth Medical, Inc. 12.8 Stentys SA 12.9 Elixir Medical Corporation 12.10 Arterius Limited 12.11 REVA Medical, Inc. 12.12 Xenogenics Corporation 12.13 Microport Scientific Corporation 12.14 Tepha, Inc. 12.15 C. R. Bard, Inc., 12.16 Terumo Corporation 12.17 Meril Life Sciences 12.18 Biotronik
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564982/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|